We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




French Team Identifies Antidote for Ricin Toxin

By LabMedica International staff writers
Posted on 25 May 2010
A large team of French researchers has discovered two low molecular weight compounds that block the action of ricin, a highly toxic protein often mentioned as a possible bioterror weapon.

Ricin comprises two subunits, the A-chain and the B-chain, which are linked by a disulphide bond. More...
The B-chain facilitates cell entry and intracellular transport, and it is reductively cleaved to free the A-chain, which inactivates ribosomes and shuts down protein synthesis.

A French team, headed by investigators at the Centre National de la Recherche Scientifique (Paris, France) used a cell-based assay system to screen over 16,000 compounds for the ability to block the intracellular transport of ricin toxins.

They reported in the April 16, 2010, online edition of the journal Cell that they had identified two compounds, Retro-1 and Retro-2 that were able to inhibit the retrograde transport route of ricin from the plasma membrane to the endoplasmic reticulum. Unlike other compounds that are known to block retrograde transport, Retro-1 and Retro-2 did not affect other intracellular trafficking and did not show any toxicity.

In experiments in mice, Retro-2 was shown to block the activity of ricin, if it were given prior to the toxin. It is expected that these compounds should also inhibit other toxic proteins such as the Shiga-like toxins produced by pathogens such as E. coli, Shigella, and cholera.

Related Links:

Centre National de la Recherche Scientifique



Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Verification Panels for Assay Development & QC
Seroconversion Panels
New
STI Test
RIDA GENE STI Mycoplasma Panel
New
Clostridium Difficile Test
Immunocard Toxins A&B
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The POC device rapidly predicts neonatal respiratory disease at birth in the NICU (Photo courtesy of SIME Diagnostics)

AI-Powered Lung Maturity Test Identifies Newborns at Higher Risk of Respiratory Distress

Each year, approximately 300,000 babies in the United States are born between 32 and 36 weeks' gestation, according to national health data. This group is at an elevated risk for respiratory distress,... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Pathology

view channel
Image: This image shows a second-generation version of the device that can also measure cell morphology (Photo courtesy of MIT)

Rapid Cell Density Measurement Technique to Help Predict Immunotherapy Response

The density of a cell provides valuable insights into its condition. As cells go through processes such as proliferation, differentiation, or cell death, they may gain or lose water and other molecules,... Read more

Technology

view channel
Image: Scanning electron microscopy images showing 3D micro-printed Limacon-shaped whispering-gallery-mode microcavities with different amounts of deformation (Photo courtesy of A. Ping Zhang/PolyU)

Tiny Microlaser Sensors with Supercharged Biosensing Ability to Enable Early Disease Diagnosis

Optical whispering-gallery-mode microlaser sensors function by trapping light within tiny microcavities. When target molecules bind to the cavity, they induce subtle changes in the laser’s frequency, allowing... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.